UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

Notice of Effectiveness

Effectiveness Date: December 29, 2022
Accession Number: 0001640334-22-002718
Submission Type: POS AM
CIK: 0001348362
Company Name: Lexaria Bioscience Corp.
File Number: 333-238915